|
CRYZL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.18450002531512E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.52710000492718E-08 |
| Normal-vs-Stage2 |
2.07409999999353E-05 |
| Normal-vs-Stage3 |
6.05919999999704E-05 |
| Normal-vs-Stage4 |
1.70998999999838E-05 |
| Stage1-vs-Stage2 |
7.206200E-01 |
| Stage1-vs-Stage3 |
6.432800E-01 |
| Stage1-vs-Stage4 |
4.216000E-01 |
| Stage2-vs-Stage3 |
9.611000E-01 |
| Stage2-vs-Stage4 |
5.298800E-01 |
| Stage3-vs-Stage4 |
5.934600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.97009972172191E-10 |
| Normal-vs-AfricanAmerican |
1.296310E-03 |
| Normal-vs-Asian |
3.157400E-04 |
| Caucasian-vs-AfricanAmerican |
1.082120E-02 |
| Caucasian-vs-Asian |
8.154200E-01 |
| AfricanAmerican-vs-Asian |
2.816800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.78289654945752E-11 |
| Normal-vs-Female |
1.821120E-03 |
| Male-vs-Female |
4.355700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.219900E-04 |
| Normal-vs-Extreme_Weight |
2.77639999879398E-09 |
| Normal-vs-Obese |
5.60379999999805E-05 |
| Normal-vs-Extreme_Obese |
3.217500E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.424820E-01 |
| Normal_Weight-vs-Obese |
9.557000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.066250E-01 |
| Extreme_Weight-vs-Obese |
9.048300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.822400E-01 |
| Obese-vs-Extreme_Obese |
8.917900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.081900E-03 |
| Normal-vs-Age(41-60Yrs) |
6.6472000004314E-07 |
| Normal-vs-Age(61-80Yrs) |
3.55609985902561E-10 |
| Normal-vs-Age(81-100Yrs) |
7.92020000000004E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.345200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.100600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.679200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.209430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.542000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.854000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.16549994497473E-09 |
| Normal-VS-Type2 PRCC |
7.5949999622793E-09 |
| Normal-VS-KIRP CIMP |
6.45579999999368E-05 |
| Normal-VS-Unclassified PRCC |
4.04490000005531E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.802200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.970400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.431000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.369800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.474800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.084000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66670000023572E-08 |
| Normal-vs-N1 |
4.835800E-04 |
| Normal-vs-N2 |
1.77675999999405E-05 |
| N0-vs-N1 |
4.065600E-01 |
| N0-vs-N2 |
2.600000E-01 |
| N1-vs-N2 |
1.436850E-01 |
|
|
